Compounds > medroxyprogesterone acetate
Page last updated: 2024-08-17

medroxyprogesterone acetate and Epithelial Ovarian Cancer

medroxyprogesterone acetate has been researched along with Epithelial Ovarian Cancer in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Badmann, S; Beyer, S; Burges, A; Buschmann, C; Chelariu-Raicu, A; Czogalla, B; Hester, A; Jeschke, U; Kolben, T; Kraus, F; Mahner, S; Mayr, D; Schmoeckel, E; Trillsch, F1
Berchuck, A; Cho, KR; Cramer, DW; Doherty, JA; Goodman, MT; Hanley, GE; Harris, HR; Jordan, SJ; Lee, AW; McLean, K; Modugno, F; Moysich, KB; Mukherjee, B; Pearce, CL; Phung, MT; Pike, MC; Schildkraut, JM; Terry, KL; Titus, LJ; Webb, PM; Wu, AH1
Bunyapipat, S; Chindavijak, S; Chotivanich, K; Hamontri, S; Ittiwisavakul, K; Khemapech, N; Kietpeerakool, C; Linasmita, V; Lumbiganon, P; Suekwattana, P; Suraseranivong, V; Tanapat, Y; Thanapprapasr, D; Therasakvichya, S; Vipupinyo, C; Wilailak, S1

Other Studies

3 other study(ies) available for medroxyprogesterone acetate and Epithelial Ovarian Cancer

ArticleYear
AKR1C1/2 inhibition by MPA sensitizes platinum resistant ovarian cancer towards carboplatin.
    Scientific reports, 2022, 02-03, Volume: 12, Issue:1

    Topics: 20-Hydroxysteroid Dehydrogenases; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Humans; Hydroxysteroid Dehydrogenases; Medroxyprogesterone Acetate; Middle Aged; NF-E2-Related Factor 2; Ovarian Neoplasms

2022
Depot-Medroxyprogesterone Acetate Use Is Associated with Decreased Risk of Ovarian Cancer: The Mounting Evidence of a Protective Role of Progestins.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2021, Volume: 30, Issue:5

    Topics: Adult; Carcinoma, Ovarian Epithelial; Case-Control Studies; Contraceptive Agents, Hormonal; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Ovarian Neoplasms; Progestins; Risk Assessment

2021
Depot medroxyprogesterone acetate and epithelial ovarian cancer: a multicentre case-control study.
    BJOG : an international journal of obstetrics and gynaecology, 2012, Volume: 119, Issue:6

    Topics: Carcinoma, Ovarian Epithelial; Case-Control Studies; Contraceptive Agents, Female; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Risk Factors; Self Report; Thailand

2012